Literature DB >> 18519406

New targets for lymphoma treatment.

P W M Johnson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18519406     DOI: 10.1093/annonc/mdn198

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

Review 1.  Novel CD20 monoclonal antibodies for lymphoma therapy.

Authors:  Shundong Cang; Nikhil Mukhi; Kemeng Wang; Delong Liu
Journal:  J Hematol Oncol       Date:  2012-10-11       Impact factor: 17.388

Review 2.  Targeted therapy in lymphoma.

Authors:  Patrick B Johnston; RuiRong Yuan; Franco Cavalli; Thomas E Witzig
Journal:  J Hematol Oncol       Date:  2010-11-23       Impact factor: 17.388

3.  Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy.

Authors:  Ho Cheol Shin; Jongwon Seo; Byung Woog Kang; Joon Ho Moon; Yee Soo Chae; Soo Jung Lee; Yoo Jin Lee; Seoae Han; Sang Kyung Seo; Jong Gwang Kim; Sang Kyun Sohn; Tae-In Park
Journal:  Korean J Intern Med       Date:  2014-10-31       Impact factor: 2.884

4.  Rituximab and new regimens for indolent lymphoma: a brief update from 2012 ASCO Annual Meeting.

Authors:  Jiangning Zhao; Zhenshu Xu; Delong Liu; Quanyi Lu
Journal:  Cancer Cell Int       Date:  2012-08-23       Impact factor: 5.722

5.  Gossypol toxicity from cottonseed products.

Authors:  Ivana Cristina N Gadelha; Nayanna Brunna S Fonseca; Silvia Catarina S Oloris; Marília M Melo; Benito Soto-Blanco
Journal:  ScientificWorldJournal       Date:  2014-05-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.